Hubble Therapeutics, LLC — Form D

Hubble Therapeutics, LLC of HANOVER, NH, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-21. The offering totals $11.1M, of which $9.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-10-21
• Form: D
• Accession: 0002038883-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $11.1M
• Amount sold: $9.8M
• Remaining: $1.3M
• Investors: 17
• Date of first sale: 2024-10-09
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-527330

Issuer

• Name: Hubble Therapeutics, LLC
• CIK: 0002038883
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 35 SOUTH MAIN STREET, HANOVER, NH, 03755
• Phone: (617) 780-2375

Officers, directors & promoters (4)

More

• CIK 2038883 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search